Edward T Ryan Selected Research

Cholera Vaccines

11/2021	Scalable production and immunogenicity of a cholera conjugate vaccine.
10/2021	Systemic, Mucosal, and Memory Immune Responses following Cholera.
1/2021	Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.
1/2021	Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine.
1/2021	Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.
1/2019	Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults.
1/2019	Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
1/2019	Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae.
12/2016	Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells.
10/2016	Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South Sudan.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edward T Ryan Research Topics

Disease

74	Cholera 11/2022 - 08/2003
65	Infections 12/2022 - 07/2003
22	Typhoid Fever (Typhoid) 10/2020 - 09/2006
14	Diarrhea 10/2020 - 10/2004
11	COVID-19 12/2022 - 05/2020
5	Inflammation (Inflammations) 01/2022 - 09/2009
5	Malaria 12/2017 - 09/2006
4	Dehydration (Water Stress) 01/2021 - 11/2009
4	Bacteremia 01/2016 - 09/2006
3	Bacterial Infections (Bacterial Infection) 10/2020 - 10/2011
3	Japanese Encephalitis 01/2019 - 10/2014
3	Rabies (Hydrophobia) 01/2019 - 02/2014
3	Convalescence 01/2016 - 04/2015
2	Measles 06/2022 - 01/2017
2	Yellow Fever 12/2017 - 05/2013
2	Human Influenza (Influenza) 07/2016 - 01/2016
2	Hepatitis A (Hepatitis, Infectious) 07/2016 - 02/2012
2	Communicable Diseases (Infectious Diseases) 11/2015 - 12/2011
2	Cryptosporidiosis 02/2012 - 07/2011
2	Bacillary Dysentery (Shigellosis) 09/2009 - 02/2006
1	Coronavirus Infections 03/2022
1	Acute Disease 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Disease Progression 12/2020
1	Respiratory Insufficiency (Respiratory Failure) 12/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020

Drug/Important Bio-Agent (IBA)

49	AntigensIBA 11/2021 - 07/2003
31	VaccinesIBA 11/2022 - 06/2003
30	AntibodiesIBA 12/2022 - 08/2003
28	Immunoglobulin A (IgA)IBA 01/2021 - 08/2003
26	Immunoglobulin G (IgG)IBA 03/2022 - 10/2004
22	LipopolysaccharidesIBA 01/2021 - 08/2003
21	Cholera Vaccines FDA Link 11/2021 - 08/2006
21	Cholera ToxinIBA 01/2021 - 08/2003
16	O Antigens (O Antigen)IBA 11/2021 - 11/2012
14	Immunoglobulin M (IgM)IBA 03/2022 - 10/2004
12	Proteins (Proteins, Gene)FDA Link 04/2019 - 07/2003
9	Conjugate VaccinesIBA 11/2021 - 10/2011
9	EnzymesIBA 10/2020 - 10/2008
8	Polysaccharides (Glycans)IBA 11/2022 - 06/2013
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2008
8	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 11/2009
6	Blood Group Antigens (Blood Groups)IBA 01/2021 - 11/2005
4	Nucleic AcidsIBA 12/2021 - 11/2015
4	ImmunosorbentsIBA 10/2020 - 10/2013
4	shancholIBA 10/2016 - 05/2014
4	CytokinesIBA 03/2015 - 08/2011
3	cholera vaccine CVD 103-HgRIBA 01/2021 - 08/2006
3	Monoclonal AntibodiesIBA 01/2021 - 12/2016
3	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2021 - 02/2014
3	Hemolysin Proteins (Hemolysins)IBA 10/2020 - 03/2014
3	Pharmaceutical PreparationsIBA 01/2019 - 02/2006
2	Neuraminidase (Sialidase)IBA 01/2021 - 12/2016
2	Complement System Proteins (Complement)IBA 01/2021 - 08/2009
2	CarbohydratesIBA 01/2021 - 05/2015
2	Phosphates (Orthophosphate)IBA 01/2021 - 01/2021
2	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link 01/2019 - 08/2010
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 10/2008
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 03/2015
2	InterferonsIBA 01/2018 - 06/2011
2	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2017 - 07/2016
2	MicronutrientsIBA 11/2016 - 11/2008
2	DukoralIBA 10/2013 - 05/2011
2	Bacterial Proteins (Bacterial Protein)IBA 05/2013 - 09/2006
2	N 30IBA 01/2013 - 05/2011
2	Vitamin A (Retinol)FDA LinkGeneric 11/2008 - 04/2008
1	EpitopesIBA 12/2022
1	Peptides (Polypeptides)IBA 12/2022
1	phenylalanylphenylalanineIBA 06/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Bacterial PolysaccharidesIBA 11/2021
1	colitoseIBA 01/2021
1	IronIBA 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	BuffersIBA 01/2021
1	Lipopolysaccharide ReceptorsIBA 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	Viral AntigensIBA 12/2020
1	Viral ProteinsIBA 12/2020
1	RNA (Ribonucleic Acid)IBA 10/2020
1	C-Reactive ProteinIBA 10/2020
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	SARS-CoV-2 spike proteinIBA 10/2020
1	Neutralizing AntibodiesIBA 10/2020
1	Coronavirus ReceptorsIBA 01/2020
1	CD40 Ligand (CD40L)IBA 04/2019
1	FluoroquinolonesIBA 01/2019
1	Third Generation CephalosporinsIBA 01/2019
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2019
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2019
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2019
1	Chloramphenicol (Chloromycetin)FDA Link 01/2019
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2019
1	Interleukin-23 (Interleukin 23)IBA 01/2019
1	OligosaccharidesIBA 01/2019

Therapy/Procedure

7	Therapeutics 01/2018 - 02/2006
6	Chemoprevention 12/2017 - 09/2006
2	Fluid Therapy (Oral Rehydration Therapy) 01/2018 - 05/2017